Pharming Group (PHGN) Ratios
Pharming Group Ratios
DE:PHGN's free cash flow for Q3 2026 was $32.11M. For the 2026 fiscal year, DE:PHGN's free cash flow was decreased by $-280.77K and operating cash flow was $32.39M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.59 | 3.65 | 4.06 | 4.65 | 5.33 |
| Quick Ratio | 2.03 | 2.92 | 3.33 | 3.94 | 4.75 |
| Cash Ratio | 1.26 | 0.72 | 0.79 | 3.47 | 4.10 |
| Solvency Ratio | 0.06 | -0.00 | 0.02 | 0.12 | 0.17 |
| Operating Cash Flow Ratio | 0.45 | -0.02 | -0.22 | 0.38 | 0.77 |
| Short-Term Operating Cash Flow Coverage | 9.74 | -0.42 | -9.49 | 12.95 | 14934.17 |
| Net Current Asset Value | $ 76.62M | $ 99.73M | $ 72.27M | $ 56.34M | $ 45.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.28 | 0.37 | 0.39 | 0.41 |
| Debt-to-Equity Ratio | 0.42 | 0.51 | 0.78 | 0.81 | 0.84 |
| Debt-to-Capital Ratio | 0.29 | 0.34 | 0.44 | 0.45 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.26 | 0.38 | 0.38 | 0.39 |
| Financial Leverage Ratio | 1.80 | 1.81 | 2.12 | 2.08 | 2.06 |
| Debt Service Coverage Ratio | 1.52 | 0.77 | 1.46 | 4.63 | 7.10 |
| Interest Coverage Ratio | 1.95 | -0.41 | -0.82 | 3.51 | 4.71 |
| Debt to Market Cap | 0.10 | 0.13 | 0.16 | 0.13 | 0.18 |
| Interest Debt Per Share | 0.18 | 0.18 | 0.22 | 0.19 | 0.19 |
| Net Debt to EBITDA | -0.87 | 4.20 | 11.12 | -1.21 | -0.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 87.90% | 88.13% | 89.72% | 91.46% | 89.37% |
| EBIT Margin | 5.78% | 1.04% | -2.47% | 9.89% | 15.36% |
| EBITDA Margin | 9.25% | 4.59% | 4.03% | 16.31% | 25.69% |
| Operating Profit Margin | 5.55% | -1.23% | -1.99% | 8.87% | 14.66% |
| Pretax Profit Margin | 3.42% | -2.86% | -4.90% | 7.29% | 11.60% |
| Net Profit Margin | 0.79% | -3.71% | -4.30% | 6.65% | 8.43% |
| Continuous Operations Profit Margin | 0.67% | -3.99% | -4.30% | 6.65% | 8.43% |
| Net Income Per EBT | 23.10% | 129.79% | 87.81% | 91.24% | 72.60% |
| EBT Per EBIT | 61.52% | 231.71% | 246.17% | 82.20% | 79.14% |
| Return on Assets (ROA) | 0.59% | -2.75% | -2.28% | 3.21% | 4.03% |
| Return on Equity (ROE) | 1.07% | -4.97% | -4.82% | 6.68% | 8.30% |
| Return on Capital Employed (ROCE) | 5.43% | -1.13% | -1.27% | 4.98% | 7.95% |
| Return on Invested Capital (ROIC) | 1.05% | -1.11% | -1.10% | 4.48% | 5.47% |
| Return on Tangible Assets | 0.81% | -3.25% | -2.69% | 3.90% | 5.11% |
| Earnings Yield | 0.29% | -1.73% | -1.25% | 1.43% | 2.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.87 | 5.92 | 5.76 | 10.50 | 11.95 |
| Payables Turnover | 0.43 | 3.50 | 1.74 | 2.89 | 3.93 |
| Inventory Turnover | 0.70 | 0.64 | 0.44 | 0.41 | 0.74 |
| Fixed Asset Turnover | 15.69 | 12.31 | 7.33 | 5.25 | 5.73 |
| Asset Turnover | 0.75 | 0.74 | 0.53 | 0.48 | 0.48 |
| Working Capital Turnover Ratio | 1.95 | 1.35 | 1.08 | 0.98 | 0.98 |
| Cash Conversion Cycle | -275.83 | 532.04 | 675.15 | 788.17 | 431.01 |
| Days of Sales Outstanding | 53.09 | 61.64 | 63.41 | 34.75 | 30.53 |
| Days of Inventory Outstanding | 520.70 | 574.57 | 821.73 | 879.68 | 493.38 |
| Days of Payables Outstanding | 849.62 | 104.17 | 209.98 | 126.27 | 92.91 |
| Operating Cycle | 573.80 | 636.21 | 885.13 | 914.44 | 523.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.07 | -0.00 | -0.02 | 0.03 | 0.04 |
| Free Cash Flow Per Share | 0.07 | -0.00 | -0.02 | 0.02 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 66.66 | -2.27 | -11.82 | 11.58 | 2.26 |
| Capital Expenditure Coverage Ratio | 66.66 | -2.27 | -11.82 | 11.58 | 2.26 |
| Operating Cash Flow Coverage Ratio | 0.45 | -0.02 | -0.10 | 0.14 | 0.22 |
| Operating Cash Flow to Sales Ratio | 0.14 | -0.01 | -0.07 | 0.11 | 0.19 |
| Free Cash Flow Yield | 4.96% | -0.41% | -2.22% | 2.18% | 2.97% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 348.78 | -58.18 | -80.20 | 70.07 | 42.46 |
| Price-to-Sales (P/S) Ratio | 2.74 | 2.15 | 3.45 | 4.66 | 3.58 |
| Price-to-Book (P/B) Ratio | 3.72 | 2.87 | 3.87 | 4.68 | 3.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.17 | -246.72 | -45.08 | 45.80 | 33.68 |
| Price-to-Operating Cash Flow Ratio | 19.86 | -355.31 | -48.89 | 41.85 | 18.80 |
| Price-to-Earnings Growth (PEG) Ratio | -2.78 | -2.40 | 0.46 | -4.38 | -0.75 |
| Enterprise Value Multiple | 28.80 | 50.92 | 96.76 | 27.36 | 13.31 |
| Enterprise Value | 1.00B | 694.84M | 955.72M | 917.53M | 649.11M |
| EV to EBITDA | 28.80 | 50.92 | 96.76 | 27.36 | 13.31 |
| EV to Sales | 2.66 | 2.34 | 3.90 | 4.46 | 3.42 |
| EV to Free Cash Flow | 19.57 | -268.92 | -50.93 | 43.86 | 32.18 |
| EV to Operating Cash Flow | 19.28 | -387.27 | -55.24 | 40.07 | 17.97 |
| Tangible Book Value Per Share | 0.20 | 0.23 | 0.18 | 0.15 | 0.12 |
| Shareholders’ Equity Per Share | 0.38 | 0.32 | 0.27 | 0.23 | 0.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.80 | -0.39 | 0.12 | 0.09 | 0.31 |
| Revenue Per Share | 0.52 | 0.43 | 0.30 | 0.23 | 0.22 |
| Net Income Per Share | 0.00 | -0.02 | -0.01 | 0.02 | 0.02 |
| Tax Burden | 0.23 | 1.30 | 0.88 | 0.91 | 0.73 |
| Interest Burden | 0.59 | -2.76 | 1.99 | 0.74 | 0.76 |
| Research & Development to Revenue | 0.27 | 0.26 | 0.28 | 0.26 | 0.35 |
| SG&A to Revenue | 0.31 | 0.33 | 0.33 | 0.22 | 0.19 |
| Stock-Based Compensation to Revenue | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 |
| Income Quality | 4.04 | 0.16 | 1.44 | 1.53 | 1.64 |
Currency in EUR
